Suchergebnisse - "Schmitz, Katharina S"

PubPharm (7)

1

A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial

enthalten in: Vaccine | 2023

von Schmitz, K. | Comvalius, A. | Nieuwkoop, N. | +7

2

Durability of Immune Responses After Boosting in Ad26.COV2.S-Primed Healthcare Workers

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Sablerolles, R. | Rietdijk, W. | Goorhuis, A. | +18

3

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Sanders, J. | Messchendorp, A. | de Vries, R. | +37

4

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

enthalten in: Nature medicine | 2023

von Zaeck, L. | Lamers, M. | Verstrepen, B. | +16

5

Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern

enthalten in: mBio | 2022

von Schmitz, K. | Geers, D. | de Vries, R. | +7

6

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

enthalten in: The New England journal of medicine | 2022

von Sablerolles, R. | Rietdijk, W. | Goorhuis, A. | +38

7

SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees

enthalten in: Science immunology | 2021

von Geers, D. | Shamier, M. | Bogers, S. | +22

1
[1]